Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

BioStock: BrainCool's new CEO on his visions for the company

BrainCool

BrainCool has strong momentum right now. Karolinska Institutet has initiated patient recruitment for a cardiac arrest study with the company's device RhinoChill, and a recently completed rights issue was subscribed to a total of 171 per cent. BioStock contacted the new CEO Jon Berg for a status update and to learn more about his visions for the company.
- BrainCool is in an exciting phase and, we believe there is a great market potential and global demand for our cooling devices, says Berg.

Read the full interview with Jon Berg at biostock.se:

https://www.biostock.se/en/2024/06/braincools-new-ceo-on-his-visions-for-the-company/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.